Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Akoya Biosciences, Inc.

AKYANASDAQ
Healthcare
Medical - Instruments & Supplies
$1.29
$-0.07(-5.15%)
U.S. Market opens in 15h 52m

Akoya Biosciences, Inc. (AKYA) Stock Overview

Explore Akoya Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap64.4M
P/E Ratio-1.86
EPS (TTM)$-0.96
ROE-6.72%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

AKYA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Akoya Biosciences, Inc. (AKYA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.86 and a market capitalization of 64.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
14.16%
6-Month Change
-47.56%
Year-to-Date (YTD) Change
-46.91%
1-Year Change
-34.18%
3-Year Change
-91.41%
5-Year Change
-93.55%
All-Time (Max) Change
-93.55%

Contact Information

855 896 8401
100 Campus Drive, Marlborough, MA, 01752

Company Facts

2,050 Employees
IPO DateApr 16, 2021
CountryUS

Frequently Asked Questions